IBT
RSLS

International Biotechnology Trust’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

International Biotechnology Trust’s Portfolio RSLS Stock Details RSLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-375
Closed -$2K – 57
2018
Q3 		$2K Hold
375
– – ﹤0.01% 51
2018
Q2 		$121K Hold
375
– – 0.05% 54
2018
Q1 		$1.14M Hold
375
– – 0.45% 48
2017
Q4 		$1.15M Buy
+375
New +$1.24M 0.41% 51

Other funds holding RSLS

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

International Biotechnology Trust's RSLS Position: Q4 2018 in Review

International Biotechnology Trust sold out of ReShape Lifesciences Inc. Common Stock (RSLS) in Q4 2018, closing a stake of 375 shares — an estimated $2K sold.

International Biotechnology Trust first reported a position in RSLS in Q4 2017 and held it in 4 quarters. The position peaked at $1.15M in Q4 2017. 2 funds tracked by Wall St. Rank hold RSLS as of Q4 2018.

  • International Biotechnology Trust reported no remaining ReShape Lifesciences Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 375 ReShape Lifesciences Inc. Common Stock shares in Q4 2018, an estimated $2K.
  • International Biotechnology Trust first reported a position in ReShape Lifesciences Inc. Common Stock in Q4 2017 and held it in 4 quarters.
  • International Biotechnology Trust's ReShape Lifesciences Inc. Common Stock position peaked at $1.15M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q4 2018.

Based on International Biotechnology Trust's 13F filing for Q4 2018, filed 14 Feb 2019.